Highlights

  • Expansion expected to generate USD 12– USD 18M in annualised recurring revenue from 2026.
  • Rollout to cover 10–15 U.S. states targeting 20,000–30,000 rural patients.
  • Follows Evolent Care Partners’ integration into Privia Health, expanding access to 1.5M-member portfolio.

Vitasora Health Limited (ASX:VHL) announced the expansion of its agreement with Evolent Care Partners (ECP), owned by Evolent Health Inc. (NYSE:EVH), to deliver Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) services across the U.S. mainland. This follows the success of its Hawaii pilot program launched in 2024.

The expanded program will extend Vitasora’s connected care services to rural populations under the Medicare Shared Savings Program (MSSP) and Medicare Fee-for-Service (FFS) models. The initiative is forecast to generate an estimated USD 12– USD 18 million in annualised recurring revenue, depending on the care mix.

Evolent highlighted the success of its Hawaii partnership with Vitasora as a key driver behind the national expansion decision.

Evolent Care Partners Joins Privia Health

Evolent Health Inc. has announced the divestiture of its value-based primary care business, Evolent Care Partners (ECP), to Privia Health Group (NASDAQ: PRVA) — a physician-led organization with approximately 1.5 million lives under management and a market capitalisation of around USD 3B.

Privia Health’s national network supports independent physician practices, providing technology, capital, and resources that enhance value-based care delivery. ECP has shown nearly 100% growth over the past two years and is regarded as a leading MSSP option for independent primary care providers, including in Hawaii where Vitasora already provides CCM services.

For Vitasora, the ECP integration into Privia represents a significant opportunity to scale services across multiple states and patient populations within Privia’s extensive footprint.

Program Scope and Revenue Impact

The program is set to expand across 10–15 U.S. mainland states, subject to contracting and rollout schedules. It will engage thousands of independent primary care physicians within the Evolent Care Partners and Privia Health networks. During the initial rollout phase in 2026, the program aims to enrol between 20,000 and 30,000 patients, with the potential to extend across Privia’s approximately 1.5-million-member portfolio. The initiative is forecast to generate annualised revenue of around USD 12– USD 18 million, depending on the care mix, which ranges from USD 35 to USD 70 per patient per month (PPPM). The nationwide rollout is expected to be execution-ready within 60–90 days, with revenue anticipated to commence 30–60 days following patient enrolment. Meaningful revenue contribution is expected from the first half of CY2026, with progressive scaling through the third and fourth quarters of the year as additional states are onboarded.

Management Commentary

Marjan Mikel, CEO of Vitasora, said:

“Our Hawaii program has demonstrated the power of connected care when supported by committed provider networks. While there is still work ahead to ensure the seamless rollout of this clinical program across the US, the Evolent expansion represents a highly significant revenue opportunity for Vitasora, that is pivotal to our path to profitability and further substantial revenue growth in 2026.”

Share Performance

The company is currently trading at AUD 0.033per share, up by 26.92% from its previous close of AUD 0.026